arrow
D

D. Timmerman

KU Leuven
H指数:94
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Imaging in gynecological disease (31): clinical and ultrasound characteristics of ovarian mature cystic teratomas containing malignancies

妇科疾病影像学(31):含恶性成分的卵巢成熟性囊性畸胎瘤的临床及超声特征

2026-05-110
PRE
Terms, definitions and measurements to describe the sonographic features of adnexal tumors: updated consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group

术语、定义和测量方法:描述附件肿瘤的超声特征——国际卵巢肿瘤分析(IOTA)小组的更新共识意见

2026-04-080
OAAI
Developing and validating ultrasound-based machine-learning models incorporating radiomics features to predict malignancy in adnexal masses

开发和验证基于超声的机器学习模型,整合放射组学特征以预测附件肿块的恶性程度

2026-03-300
OAAI
Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance

评估预测人工智能模型中用于支持医疗决策的性能指标:概述与指导

2025-12-130
OAAI
ADNEX-AI: automated extraction of ultrasound predictors for interpretable ovarian cancer risk stratification

ADNEX-AI:用于可解释卵巢癌风险分层的超声预测因子自动提取

2025-12-110
OAAI
Circulating Tumor DNA in the Diagnosis of Ovarian Cancer: A Systematic Review

循环肿瘤DNA在卵巢癌诊断中的应用:一项系统综述

2025-10-060
OAAI
Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors

血清蛋白在预测卵巢肿瘤恶性风险中增加的临床和超声信息价值

2025-10-060
OAAI
Head-to-head comparison of the RMI and ADNEX models to estimate the risk of ovarian malignancy: a systematic review and meta-analysis of external validation studies

RMI和ADNEX模型在估计卵巢恶性风险方面的头对头比较:一项对外部验证研究的系统评价和荟萃分析

2025-10-010
PRE
External validation of ultrasound-based models for differentiating between benign and malignant adnexal masses: a nationwide prospective multicenter study (IOTA phase 6)

基于超声模型的区分良性及恶性附件肿块的外部验证:一项全国性前瞻性多中心研究(IOTA第6阶段)

2025-07-110
OAAI
Addendum to consensus opinion from the International Deep Endometriosis Analysis (IDEA) group: sonographic evaluation of superficial endometriosis

国际深部子宫内膜异位症分析(IDEA)小组共识意见的补充:浅表子宫内膜异位症的超声评估

2025-07-090
OAAI
Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer

Kwong, F.L.A.; Kristunas, C.; Davenport, C.; Deeks, J.; Mallett, S.; Agarwal, R.; Kehoe, S.; Timmerman, D.; Bourne, T.; Stobart, H.; 等. 症状触发检测可发现早期和低体积可切除晚期卵巢癌。Int. J. Gynecol. Cancer, 2024; 已录用. [Google Scholar] [CrossRef] [PubMed]

2025-04-220
PRE